These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 29803592)

  • 1. Health care worker perceptions toward computerized clinical decision support tools for Clostridium difficile infection reduction: A qualitative study at 2 hospitals.
    Blanco N; O'Hara LM; Robinson GL; Brown J; Heil E; Brown CH; Stump BD; Sigler BW; Belani A; Miller HL; Chiplinski AN; Perlmutter R; Wilson L; Morgan DJ; Leekha S
    Am J Infect Control; 2018 Oct; 46(10):1160-1166. PubMed ID: 29803592
    [TBL] [Abstract][Full Text] [Related]  

  • 2.
    Legenza L; Barnett S; Rose W; Safdar N; Emmerling T; Peh KH; Coetzee R
    Antimicrob Resist Infect Control; 2018; 7():125. PubMed ID: 30386594
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The burden of healthcare-associated Clostridium difficile infection in a non-metropolitan setting.
    Bond SE; Boutlis CS; Yeo WW; Pratt WAB; Orr ME; Miyakis S
    J Hosp Infect; 2017 Apr; 95(4):387-393. PubMed ID: 28131640
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of a national 4C antibiotic stewardship intervention on the clinical and molecular epidemiology of Clostridium difficile infections in a region of Scotland: a non-linear time-series analysis.
    Lawes T; Lopez-Lozano JM; Nebot CA; Macartney G; Subbarao-Sharma R; Wares KD; Sinclair C; Gould IM
    Lancet Infect Dis; 2017 Feb; 17(2):194-206. PubMed ID: 27825595
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multihospital outbreak of Clostridium difficile ribotype 027 infection: epidemiology and analysis of control measures.
    Aldeyab MA; Devine MJ; Flanagan P; Mannion M; Craig A; Scott MG; Harbarth S; Vernaz N; Davies E; Brazier JS; Smyth B; McElnay JC; Gilmore BF; Conlon G; Magee FA; Elhajji FW; Small S; Edwards C; Funston C; Kearney MP
    Infect Control Hosp Epidemiol; 2011 Mar; 32(3):210-9. PubMed ID: 21460505
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Practice measures for controlling and preventing hospital associated Clostridium difficile infections.
    Ramai D; Noorani A; Ofosu A; Ofori E; Reddy M; Gasperino J
    Hosp Pract (1995); 2019 Aug; 47(3):123-129. PubMed ID: 31177865
    [No Abstract]   [Full Text] [Related]  

  • 7. Impact of a C. difficile infection (CDI) reduction bundle and its components on CDI diagnosis and prevention.
    Blanco N; Robinson GL; Heil EL; Perlmutter R; Wilson LE; Brown CH; Heavner MS; Nadimpalli G; Lemkin D; Morgan DJ; Leekha S
    Am J Infect Control; 2021 Mar; 49(3):319-326. PubMed ID: 33640109
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An evaluation of the impact of antibiotic stewardship on reducing the use of high-risk antibiotics and its effect on the incidence of Clostridium difficile infection in hospital settings.
    Aldeyab MA; Kearney MP; Scott MG; Aldiab MA; Alahmadi YM; Darwish Elhajji FW; Magee FA; McElnay JC
    J Antimicrob Chemother; 2012 Dec; 67(12):2988-96. PubMed ID: 22899806
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of an antimicrobial stewardship bundle for patients with Clostridium difficile infection.
    Brumley PE; Malani AN; Kabara JJ; Pisani J; Collins CD
    J Antimicrob Chemother; 2016 Mar; 71(3):836-40. PubMed ID: 26661392
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A qualitative, interprofessional analysis of barriers to and facilitators of implementation of the Department of Veterans Affairs' Clostridium difficile prevention bundle using a human factors engineering approach.
    Yanke E; Moriarty H; Carayon P; Safdar N
    Am J Infect Control; 2018 Mar; 46(3):276-284. PubMed ID: 29269166
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clostridium difficile contamination of health care workers' hands and its potential contribution to the spread of infection: Review of the literature.
    Jullian-Desayes I; Landelle C; Mallaret MR; Brun-Buisson C; Barbut F
    Am J Infect Control; 2017 Jan; 45(1):51-58. PubMed ID: 28065332
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Implementation of Global Strategies to Prevent Hospital-Onset Clostridium difficile Infection: Targeting Proton Pump Inhibitors and Probiotics.
    Lewis PO; Lundberg TS; Tharp JL; Runnels CW
    Ann Pharmacother; 2017 Oct; 51(10):848-854. PubMed ID: 28821215
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibiotic stewardship teams and
    Vaughn VM; Greene MT; Ratz D; Fowler KE; Krein SL; Flanders SA; Dubberke ER; Saint S; Patel PK
    Infect Control Hosp Epidemiol; 2020 Feb; 41(2):143-148. PubMed ID: 31806059
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluating the Effectiveness of an Antimicrobial Stewardship Program on Reducing the Incidence Rate of Healthcare-Associated Clostridium difficile Infection: A Non-Randomized, Stepped Wedge, Single-Site, Observational Study.
    DiDiodato G; McArthur L
    PLoS One; 2016; 11(6):e0157671. PubMed ID: 27309536
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The projected effectiveness of Clostridium difficile vaccination as part of an integrated infection control strategy.
    van Kleef E; Deeny SR; Jit M; Cookson B; Goldenberg SD; Edmunds WJ; Robotham JV
    Vaccine; 2016 Nov; 34(46):5562-5570. PubMed ID: 27727031
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Frontline perspectives of C. difficile infection prevention practice implementation within veterans affairs health care facilities: A qualitative study.
    Parmasad V; Keating J; McKinley L; Evans C; Rubin M; Voils C; Safdar N
    Am J Infect Control; 2023 Oct; 51(10):1124-1131. PubMed ID: 36977453
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Does electronic stewardship work?
    Lambl BB; Kaufman N; Kurowski J; O'Neill W; Buckley F; Duram M; Swartz B; Phillips D; Rein M; Rubin M
    J Am Med Inform Assoc; 2017 Sep; 24(5):981-985. PubMed ID: 28371928
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Implementation strategies for hospital-based probiotic administration in a stepped-wedge cluster randomized trial design for preventing hospital-acquired Clostridioides difficile infection.
    Bresee LC; Lamont N; Ocampo W; Holroyd-Leduc J; Sabuda D; Leal J; Dalton B; Kaufman J; Missaghi B; Kim J; Larios OE; Henderson E; Raman M; Fletcher JR; Faris P; Kraft S; Shen Y; Louie T; Conly JM
    BMC Health Serv Res; 2023 Dec; 23(1):1386. PubMed ID: 38082421
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vital Signs: Preventing Antibiotic-Resistant Infections in Hospitals - United States, 2014.
    Weiner LM; Fridkin SK; Aponte-Torres Z; Avery L; Coffin N; Dudeck MA; Edwards JR; Jernigan JA; Konnor R; Soe MM; Peterson K; McDonald LC
    MMWR Morb Mortal Wkly Rep; 2016 Mar; 65(9):235-41. PubMed ID: 26963489
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Leveraging Quality Improvement Science to Reduce C. difficile Infections in a Community Hospital.
    Lambl BB; Altamimi S; Kaufman NE; Rein MS; Freeley M; Duram M; Krauss W; Kurowski J; O'Neill WE; Seeley P; Gagnon MJ; Phillips DE; Rubin MS
    Jt Comm J Qual Patient Saf; 2019 Apr; 45(4):285-294. PubMed ID: 30527394
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.